608 related articles for article (PubMed ID: 22078961)
1. Current progress and potential practical application for human pluripotent stem cells.
Philonenko ES; Shutova MV; Chestkov IV; Lagarkova MA; Kiselev SL
Int Rev Cell Mol Biol; 2011; 292():153-96. PubMed ID: 22078961
[TBL] [Abstract][Full Text] [Related]
2. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
3. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
Hussein SM; Nagy AA
Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
[TBL] [Abstract][Full Text] [Related]
4. Generation of germ cells in vitro in the era of induced pluripotent stem cells.
Imamura M; Hikabe O; Lin ZY; Okano H
Mol Reprod Dev; 2014 Jan; 81(1):2-19. PubMed ID: 23996404
[TBL] [Abstract][Full Text] [Related]
5. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
6. Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?
Boué S; Paramonov I; Barrero MJ; Izpisúa Belmonte JC
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862250
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.
Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT
Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788
[TBL] [Abstract][Full Text] [Related]
8. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
Rezanejad H; Matin MM
Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
Jozefczuk J; Prigione A; Chavez L; Adjaye J
Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
[TBL] [Abstract][Full Text] [Related]
11. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
Galach M; Utikal J
Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
[TBL] [Abstract][Full Text] [Related]
12. Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors.
Liu K; Ji G; Mao J; Liu M; Wang L; Chen C; Liu L
Cell Reprogram; 2012 Dec; 14(6):505-13. PubMed ID: 23035653
[TBL] [Abstract][Full Text] [Related]
13. Ovine induced pluripotent stem cells are resistant to reprogramming after nuclear transfer.
German SD; Campbell KH; Thornton E; McLachlan G; Sweetman D; Alberio R
Cell Reprogram; 2015 Feb; 17(1):19-27. PubMed ID: 25513856
[TBL] [Abstract][Full Text] [Related]
14. Defining pluripotent stem cells through quantitative proteomic analysis.
Reiland S; Salekdeh GH; Krijgsveld J
Expert Rev Proteomics; 2011 Feb; 8(1):29-42. PubMed ID: 21329426
[TBL] [Abstract][Full Text] [Related]
15. iPS cells: a source of cardiac regeneration.
Yoshida Y; Yamanaka S
J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
[TBL] [Abstract][Full Text] [Related]
16. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
[TBL] [Abstract][Full Text] [Related]
17. Keratinocyte growth factor and dexamethasone plus elevated cAMP levels synergistically support pluripotent stem cell differentiation into alveolar epithelial type II cells.
Schmeckebier S; Mauritz C; Katsirntaki K; Sgodda M; Puppe V; Duerr J; Schubert SC; Schmiedl A; Lin Q; Paleček J; Draeger G; Ochs M; Zenke M; Cantz T; Mall MA; Martin U
Tissue Eng Part A; 2013 Apr; 19(7-8):938-51. PubMed ID: 23176317
[TBL] [Abstract][Full Text] [Related]
18. Engineering personalized neural tissue by combining induced pluripotent stem cells with fibrin scaffolds.
Montgomery A; Wong A; Gabers N; Willerth SM
Biomater Sci; 2015 Feb; 3(2):401-13. PubMed ID: 26218131
[TBL] [Abstract][Full Text] [Related]
19. Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs.
Zhao MT; Chen H; Liu Q; Shao NY; Sayed N; Wo HT; Zhang JZ; Ong SG; Liu C; Kim Y; Yang H; Chour T; Ma H; Gutierrez NM; Karakikes I; Mitalipov S; Snyder MP; Wu JC
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11111-E11120. PubMed ID: 29203658
[TBL] [Abstract][Full Text] [Related]
20. Preferential gene expression and epigenetic memory of induced pluripotent stem cells derived from mouse pancreas.
Nukaya D; Minami K; Hoshikawa R; Yokoi N; Seino S
Genes Cells; 2015 May; 20(5):367-81. PubMed ID: 25727848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
